Cardiology
Conference Coverage
CAC scoring pinpoints stenoses in asymptomatic diabetes patients
Conference Coverage
DAPA-HF: Dapagliflozin slows T2D onset in heart failure patients
News
Lancet, NEJM retract studies on hydroxychloroquine for COVID-19
The Lancet issued a retraction of an influential study of hydroxychloroquine use in COVID-19 patients. Hours later, NEJM retracted a second study...
News
More fatalities in heart transplant patients with COVID-19
FDA/CDC
FDA okays emergency use for Impella RP in COVID-19 right heart failure
Conference Coverage
Social isolation tied to higher risk of cardiovascular events, death
“These results are especially important in the current times of social isolation during the coronavirus crisis.”
News
More evidence hydroxychloroquine is ineffective, harmful in COVID-19
New observational data show that hydroxychloroquine it is not only without benefit for COVID-19 but also increases death and arrhythmias.
News
Immunotherapy, steroids had positive outcomes in COVID-19–associated multisystem inflammatory syndrome
“Incomplete forms of Kawasaki disease occur in infants who may have fever as the sole clinical finding, whereas older patients are more prone to...